Alopecia Treatment Market - Global Forecast to 2026, by Disease Type (Androgenic Alopecia, Alopecia Areata, and Others), by Drug Type (Topical Agents, 5 AR Inhibitors, Corticosteroids, and Others), by Gender (Male and Female), by Route of Administration (Oral, Topical, and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

  • Published On : Jul 2019 |
  • Pages : 193 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Alopecia Treatment Market – Market Insights

Alopecia is the condition described for excessive hair damage or hair loss. Alopecia treatment plays a major role in advanced healthcare, as it aids in prevention of hair fall and regrowth of hair. The unhealthy lifestyle, ageing, and hormonal imbalance are some of the factors leading to alopecia condition.

The global alopecia treatment market size was valued at US$ 7,325.0 million in 2017, and is expected to exhibit a CAGR of 4.9% over the forecast period (2018–2026).

Figure 1. Global Alopecia Treatment Market Value (US$ Mn), by Region, 2018

                                                                     Source: Coherent Market Insights Analysis (2019)

Increasing product approvals, product launches, and robust pipelines are expected to propel the market growth

Rising product launch and robust pipelines are expected to drive the global alopecia treatment market. For instance, in November 2018, Fidia Pharma launched Trinov hair growth lotion for hair growth in Italy. Furthermore, in September 2018, Eli Lilly and Company initiated phase 2 clinical trial to assess the safety and efficacy of Baricitinib drug in treating patients with alopecia areata. The study is estimated to complete in August 2022.

Rising initiatives such as crowdfunding campaigns and increasing collaboration by the market players is expected to bolster the market growth. For instance, in 2018, HairClone, a U.K. based company working on cellular hair restoration therapies, launched its public crowdfunding campaign. The company collaborated with Capital Cell, a crowdfunding company. Similarly, in May 2013, RepliCel Life Sciences Inc. and Shiseido Company, Limited announced collaboration and technology development transfer framework agreement for RepliCel’s RCH-01 hair regeneration technology.

Figure 2. Global Alopecia Treatment Market Share (%), by Disease Type, 2018 and 2026

                                     

Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of Alopecia Areata and higher focus on advancing research in the North America are expected to bolster the market growth

North America holds dominant position in the global alopecia treatment market, owing to increasing prevalence of Alopecia Areata and active research activities by market players. For instance, according to the National Alopecia Areata Foundation (NAAF), 2017, alopecia areata affects around 6.8 million people in the U.S. with a lifetime risk of 2.1%. Moreover, the NAAF is focused on broadening research efforts through two committees, including the Basic Research Advisory Council (BRAC), and the Clinical Research Advisory Council (CRAC), in order to advance the Alopecia Areata Treatment Development Program

Increasing acquisition strategies in the region by the market players are major factor expected to propel the market growth. For instance, in August 2017, Aclaris Therapeutics, Inc. acquired Confluence Life Sciences, Inc., which expanded Aclaris’ inflammation and immunology pipeline with the addition of Confluence’s lead product candidates CDD-450, topical Janus kinase inhibitors, and IL2-inducible T-cell kinase inhibitor programs.

Moreover, collaboration of market players with regulatory authorities as well as other government organizations is further expected to support growth of the North America alopecia treatment market over the forecast period. For instance in April, 2019, Precision Therapeutics Inc., Helomics, and the National Alopecia Areata Foundation (NAAF), entered into an agreement to treat people affected by an autoimmune skin disease called alopecia areata. The agreement was intended to provide a next-generation patient registry to drive research on new treatments for people with this disease.

Key Players

Major players operating in the global alopecia treatment market include Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., Merck & Co., Inc., Daiichi Sankyo Company, Limited, and Sun Pharmaceutical Industries Ltd.

Alopecia is the common autoimmune disorder, which causes hair loss or sometimes it may lead to baldness. Alopecia is classified into alopecia areata, androgenic alopecia, alopecia totalis, and cicatricial alopecia. Alopecia areata is a common autoimmune disorder that results in unpredictable hair loss. In this case, the body attacks its own anagen hair follicles and suppresses or stops hair growth. Cicatricial alopecia is the condition characterized by hair loss accompanied by the formation of scars.

Market Dynamics

Increasing product launches by market players is a major factor driving global alopecia treatment market growth. For instance, in March 2016, Galderma Laboratories, L.P. announced the launch of qilib Hair Regrowth + Revitalization System and qilib Hair Health Reinforcement Biotin + Multivitamin Supplement indicated for hair thinning problem and hair loss.

Furthermore, inorganic strategies adopted by key players for enhancing their distribution network and offering best products in the market is expected to drive the market growth.  For instance, in May 2018, Cellmid Limited entered into an agreement with Beijing Fukangren Bio-pharm Tech Co Ltd. for distribution of its products across People’s Republic of China.

Key features of the study:

  • This report provides in-depth analysis of the global alopecia treatment market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global alopecia treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., Merck & Co., Inc., Daiichi Sankyo Company, Limited, and Sun Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global alopecia treatment market  report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alopecia treatment market

Detailed Segmentation:

  • Global Alopecia Treatment Market, By Disease Type:
    • Androgenic Alopecia
    • Alopecia Areata
    • Others
  • Global Alopecia Treatment Market, By Drug Type:
    • Topical Agents
    • 5 AR Inhibitors
    • Corticosteroids
    • Others
  • Global Alopecia Treatment Market, By Gender:
    • Male
    • Female
  • Global Alopecia Treatment Market, By Route of Administration:
    • Oral
    • Topical
    • Injectable
  • Global Alopecia Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Alopecia Treatment Market, By Region:
    • North America
      • By Disease Type:
        • Androgenic Alopecia
        • Alopecia Areata
        • Others
      • By Drug Type:
        • Topical Agents
        • 5 AR Inhibitors
        • Corticosteroids
        • Others
      • By Gender:
        • Male
        • Female
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Disease Type:
        • Androgenic Alopecia
        • Alopecia Areata
        • Others
      • By Drug Type:
        • Topical Agents
        • 5 AR Inhibitors
        • Corticosteroids
        • Others
      • By Gender:
        • Male
        • Female
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Disease Type:
        • Androgenic Alopecia
        • Alopecia Areata
        • Others
      • By Drug Type:
        • Topical Agents
        • 5 AR Inhibitors
        • Corticosteroids
        • Others
      • By Gender:
        • Male
        • Female
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Disease Type:
        • Androgenic Alopecia
        • Alopecia Areata
        • Others
      • By Drug Type:
        • Topical Agents
        • 5 AR Inhibitors
        • Corticosteroids
        • Others
      • By Gender:
        • Male
        • Female
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Disease Type:
        • Androgenic Alopecia
        • Alopecia Areata
        • Others
      • By Drug Type:
        • Topical Agents
        • 5 AR Inhibitors
        • Corticosteroids
        • Others
      • By Gender:
        • Male
        • Female
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Disease Type:
        • Androgenic Alopecia
        • Alopecia Areata
        • Others
      • By Drug Type:
        • Topical Agents
        • 5 AR Inhibitors
        • Corticosteroids
        • Others
      • By Gender:
        • Male
        • Female
      • By Route of Administration:
        • Oral
        • Topical
        • Injectable
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Histogen Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Cipla Limited
    • Aclaris Therapeutics, Inc.
    • Concert Pharmaceuticals, Inc.
    • Merck & Co., Inc.
    • Daiichi Sankyo Company, Limited
    • Sun Pharmaceutical Industries Ltd.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Disease Type
      • Market Snippet, By Drug Type
      • Market Snippet, By Gender
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Epidemiology
    • Collaboration and Acquisitions
    • New Product Launches
    • Market Trends
    • Regulatory Scenario
    • Merger and Acquisition Scenario
    • Key Highlights
    • PEST Analysis
  4. Global Alopecia Treatment Market, By Disease Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Androgenic Alopecia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Alopecia Areata
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. Global Alopecia Treatment Market, By Drug Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Topical Agents
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • 5 AR Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global Alopecia Treatment Market, By Gender, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Male
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Female
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Alopecia Treatment Market , By Route of Administration, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. Global Alopecia Treatment Market , By Distribution Channel, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital Pharmacies 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  9. Global Alopecia Treatment Market , By Region, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France        
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Gender, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  10. Competitive Landscape
    • Company Profiles
      • Histogen Inc.
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cipla Limited
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Aclaris Therapeutics, Inc.
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Concert Pharmaceuticals, Inc.
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Daiichi Sankyo Company, Limited
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Overview
        • Disease Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  11. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 31 market data tables and 25 figures on "Alopecia Treatment Market - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.